Early detection of poor outcome in patients with metastatic colorectal cancer: tumor kinetics evaluated by circulating tumor cells

Autor: Souza e Silva V, Chinen LTD, Abdallah EA, Damascena A, Paludo J, Chojniak R, Dettino ALA, Mello CAL, Alves VS, Fanelli MF

Publikováno v: OncoTargets and Therapy, Vol Volume 9, Pp 7503-7513 (2016)

Virgílio Souza e Silva,1 Ludmilla Thomé Domingos Chinen,2 Emne A Abdallah,2 Aline Damascena,2 Jociana Paludo,3 Rubens Chojniak,3 Aldo Lourenço Abbade Dettino,1 Celso Abdon Lopes deMello,1 Vanessa S Alves,2 Marcello F Fanelli1 1Department of Clinic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::e064e09c5ebd62b9b8eb23539396f2bb
https://www.dovepress.com/early-detection-of-poor-outcome-in--patients-with-metastatic-colorecta-peer-reviewed-article-OTT

Oral antigen administration in mice skin allograft rejection

Autor: Sato, Mn, Duarte, Ajs, Dettino, Ala

Publikováno v: Publons

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::09f987352027b22a56c9a4e1d56fe03c
https://publons.com/publon/26955498/

Development of geriatric oncology in Latin America: A report from the Latin American Cooperative Oncology Group.

Autor: de Barros LPL; Oncology and Hematology Department, HCor, São Paulo, Brazil; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil. Electronic address: luciolaplbarros@gmail.com., de Oliveira Muniz Koch L; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Oncology and Hematology Department, Hospital Israelita Albert Einstein, São Paulo, Brazil., de Oliveira Lima JT; IMIP - Instituto Medicina Integral Prof. Fernando Figueira, Recife, Brazil., Apolinario TL; IMIP - Instituto Medicina Integral Prof. Fernando Figueira, Recife, Brazil., Dettino ALA; A. C. Camargo Cancer Center, São Paulo, Brazil., Petrarca CR; Hospital FAU-UFPel, Pelotas, Brazil., Martins JC; Prevent Senior, São Paulo, Brazil., de Souza PMR; Hospital Israelita Albert Einstein, São Paulo, Brazil., Rodrigues M; Hospital Israelita Albert Einstein, São Paulo, Brazil., de Souza E Silva JT; Oncologia D'or, Brasília, Brazil., Karnakis T; Cancer Institute of São Paulo, University of São Paulo, São Paulo, Brazil., Junior LAG; Geriatric Center for Advanced Medicine, Hospital Sirio-Libanês, São Paulo, SP, Brazil., Junior MGA; Prevent Senior, São Paulo, Brazil., Honorato M; Department of Geriatrics, Clínica Alemana de Santiago, Santiago, Chile., Abalos VR; Department of Geriatrics, Clínica Alemana de Santiago, Santiago, Chile., Alvarado OC; Department of Geriatrics, Clínica Alemana de Santiago, Santiago, Chile; Complejo Asistencial Dr. Sótero del Río, Santiago, Chile., Navarrete G; Hospital Clínico Universidad de Chile, Santiago, Chile; Fundación Arturo Lopez Perez, Santiago, Chile., Rebelatto TF; Latin American Cooperative Oncology Group (LACOG), Porto Alegre, Brazil., Soto-Perez-de-Celis E; Department of Geriatrics, Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran, México City, Mexico.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2024 Apr; Vol. 15 (3), pp. 101642. Date of Electronic Publication: 2023 Nov 15.

Influence of treatment access on survival of metastatic renal cell carcinoma in brazilian cancer center.

Autor: Leite LM; Departamento de Oncologia Médica, AC Camargo Cancer Center, São Paulo, SP, Brasil., Bergerot PG; Department of Medical Oncology and Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA, USA., Dettino ALA; Departamento de Oncologia Médica, AC Camargo Cancer Center, São Paulo, SP, Brasil., R JA Júnior; Departamento de Oncologia Médica, AC Camargo Cancer Center, São Paulo, SP, Brasil., Zequi SC; Departamento de Urologia Oncológica, AC Camargo Cancer Center, São Paulo, SP, Brasil.; Instituto Nacional de Ciência e Tecnologia em Oncogenômica e Inovação Terapêutica, AC Camargo Cancer Center, São Paulo, SP, Brasil., Formiga MNDC; Departamento de Oncologia Médica, AC Camargo Cancer Center, São Paulo, SP, Brasil.; Instituto Nacional de Ciência e Tecnologia em Oncogenômica e Inovação Terapêutica, AC Camargo Cancer Center, São Paulo, SP, Brasil.

Publikováno v: International braz j urol : official journal of the Brazilian Society of Urology [Int Braz J Urol] 2021 May-Jun; Vol. 47 (3), pp. 566-573.

Consensus on the Treatment and Follow-Up for Metastatic Castration-Resistant Prostate Cancer: A Report From the First Global Prostate Cancer Consensus Conference for Developing Countries (PCCCDC).

Autor: Maluf FC; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Pereira FMT; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Silva AG; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Oncologia Clínica ICTr, Curitiba, Brazil., Dettino ALA; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital AC Camargo, São Paulo, Brazil., Cardoso APG; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Sasse AS; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo Sonhe, Campinas, Brazil., Soares A; Hospital Israelita Albert Einstein, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Centro Paulista de Oncologia, Oncoclínicas, São Paulo, Brazil., Kann AG; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital Alemão Oswaldo Cruz, São Paulo, Brazil., Herchenhorn D; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo de oncologia D'Or, Rio de Janeiro, Brazil.; Instituto D'Or de ensino e pesquisa, Rio de Janeiro, Brazil., Jardim DLF; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital Sírio Libanês, São Paulo, Brazil., Cortés DEL; Clínica Oncólogos del Occidente SAS, Manizales, Colombia., Kater FR; Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Morbeck IAP; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital Sírio Libanês, Brasília, Brazil.; Universidade Católica de Brasília, Brasília, Brazil., Reolon JFN; Beneficência Portuguesa de São Paulo, São Paulo, Brazil.; Latin American Oncology Group (LACOG), Porto Alegre, Brazil., Rinck JA Jr; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Hospital AC Camargo, São Paulo, Brazil., Zarbá JJ; Hospital Zenon Santillán, Nacional University of Tucumán, Tucumán, Argentina., Sade JP; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Instituto Alexander Fleming y de la Universidad Austral, Buenos Aires, Argentina., da Trindade KM; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; IEP-Instituto de Ensino e Pesquisa Oncocentro, Fortaleza, Brazil., Costa LAGA; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo de oncologia D'Or, Rio de Janeiro, Brazil., Dos Santos LV; Beneficência Portuguesa de São Paulo, São Paulo, Brazil., Maia MC; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Centro de Oncologia do Paraná, Curitiba, Brazil., Siqueira MB; Latin American Oncology Group (LACOG), Porto Alegre, Brazil.; Grupo de oncologia D'Or, Rio de Janeiro, Brazil., Gillessen S; Oncology Institute of Southern Switzerland (IOSI), Bellinzona and Università della Svizzera Italiana, Lugano, Switzerland.; Manchester Cancer Research Centre, Division of Cancer Sciences, University of Manchester, Manchester, United Kingdom.

Publikováno v: JCO global oncology [JCO Glob Oncol] 2021 Apr; Vol. 7, pp. 559-571.